Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 3.21M | $22.0M | 3.35% | -- | 2026-03-31 |
| Cormorant Asset Management, LP | 2.90M | $20.0M | 3.03% | -- | 2026-03-31 |
| Squadron Capital Management LLC | 1.27M | $8.0M | 1.32% | -- | 2026-03-31 |
| Balyasny Asset Management L.P. | 877.8K | $6.0M | 0.92% | -- | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 681.8K | $4.0M | 0.71% | -- | 2026-03-31 |
| Casdin Capital, LLC | 538.5K | $3.0M | 0.56% | -- | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 538.5K | $3.0M | 0.56% | -- | 2026-03-31 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 414.9K | $2.0M | 0.43% | -- | 2026-03-31 |
| Woodline Partners LP | 209.3K | $1.0M | 0.22% | -- | 2026-03-31 |
| Affinity Asset Advisors, LLC | 164.7K | $1.0M | 0.17% | -- | 2026-03-31 |
